Background Left ventricular dysfunction and cardiomyopathy are well documented adverse
effects associated with chemotherapy agents. Limited information exists regarding the …

Cardio-oncology guidelines, position statements and clinical trials have focused on the
cardiotoxic effects of cancer therapies upon the left ventricle (LV)(1, 2). However, cancer …

Purpose To investigate whether acute and transient pressure overload in patients with
pregnancy‐induced hypertension (PIH) affects left ventricular (LV) systolic function. Methods …

Background: Chemotherapeutic agents have been associated with cardiotoxicity; thus, they
require close monitoring. Several echocardiographic variables have been investigated as …

Purpose We aimed to explore the hypothesis that early subclinical cardiac chamber
dysfunction secondary to tyrosine kinase inhibitors (TKIs) in patients with metastatic renal …

Trastuzumab is a key therapy for patients with human epidermal growth factor receptor 2
positive breast cancer (BC). However, it may cause left ventricular dysfunction, resulting in …

We tested the hypothesis that left atrial (LA) mechanics and myocardial calibrated integrated
backscatter (cIB) are altered in anthracycline-treated long-term survivors of childhood …

Objectives We evaluated left atrial (LA) remodeling using cardiac MRI (CMR) in patients with
human epidermal growth factor receptor 2 (HER2)–positive breast cancer during and after …

Background Cancer therapy-related cardiotoxicity has recently become an area of intense
research. As the prognostic role of the right ventricle (RV) in a variety of cardiovascular …

A wide range of extremely effective chemotherapy drugs has a negative effect on the
cardiovascular system, leveling oncological treatment success. Early diagnosis of …